Doing bridging therapy now , Pola and Mozun. Side effects got worse by the week. Last Tuesday Was my last infusion....
I'm sorry you're experiencing these side effects—that sounds really uncomfortable. Let me help you understand what might be happening and what questions to ask your care team.
What You're Describing
The symptoms you're experiencing—numbness, itching, and swelling in your feet and toes—are consistent with peripheral neuropathy, a known side effect of both medications you're receiving:
- Polatuzumab vedotin (Pola) and mosunetuzumab (Mozun) can both cause nerve-related side effects
- These typically develop during treatment and can progress week-to-week as you've noticed
- The fact that symptoms worsened over the past week and are now visible (swelling, irritation) suggests this needs prompt evaluation
Why This Matters
According to NCCN Guidelines, side effects from lymphoma treatment require active monitoring and management because:
- Early intervention helps - Catching neuropathy early can sometimes prevent it from worsening
- It affects function - Foot numbness and swelling can impact your ability to walk safely and your quality of life
- It can indicate dose-related toxicity - Your care team needs to know the severity to make decisions about future treatment
What You Should Do RIGHT NOW
Contact your oncology team TODAY - don't wait for a scheduled appointment. Specifically tell them:
- When the numbness started (about a week ago)
- That swelling and skin irritation appeared yesterday
- That symptoms are worsening despite finishing your last infusion
- Ask if you should be seen urgently or go to the ER
Important questions to ask your care team:
- "Is this peripheral neuropathy, and how severe is it?" - They may grade it on a scale (Grade 1-4)
- "Do I need to be examined today or should I go to urgent care/ER?" - Swelling + numbness can sometimes indicate other issues that need quick evaluation
- "Will this affect my next treatment plan?" - Neuropathy severity may influence timing or type of bridging therapy
- "What can I do to manage the numbness and swelling right now?" - There are supportive care options
- "Is this expected to improve after treatment ends, or will it be long-term?" - Understanding the timeline helps with planning
Why the Timing Matters
Even though your last infusion was Tuesday, these medications can continue affecting your body for days or weeks. The fact that swelling appeared after your last dose doesn't mean it's unrelated—it's actually common for side effects to peak or become visible after treatment ends.
Supportive Care Options
According to NCCN Guidelines for managing treatment side effects, your team may recommend:
- Elevation and compression for swelling
- Gentle skin care (the irritation needs attention to prevent infection)
- Medications to manage neuropathic pain/numbness (gabapentin, pregabalin, or others)
- Monitoring for signs of infection (especially important with swollen, irritated skin)
Bottom Line
This needs to be evaluated by your oncology team today. Swelling + numbness + skin irritation is a combination that warrants prompt assessment, especially since it's progressing. Your care team needs to:
- Rule out other causes (infection, blood clots, etc.)
- Grade the severity of neuropathy
- Decide if this affects your upcoming treatment schedule
- Start supportive care if needed
Don't minimize this or wait—call your oncology clinic now and describe exactly what you told me. If you can't reach them or they say to wait, consider urgent care or the ER, especially if the swelling worsens or you develop warmth, redness, or signs of infection.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Grounded in NCCN Guidelines for Patients (Lymphomas) — the same guidelines oncologists use.
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated October 3, 2026. Informational only — not a substitute for your oncology team.
Question asked:
Doing bridging therapy now , Pola and Mozun. Side effects got worse by the week. Last Tuesday Was my last infusion. Yesterday, my toes were num, and itchy, when I took my socks off my feet were irritated and swelling, it started being num a week ago but I haven’t looked at it until yesterday. I...
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients (Lymphomas) (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with treatment for Lymphoma patients
Have your records handy? Add them to a private case for a deeper, personalized read →
Expert Webinars on Lymphoma
More questions about Lymphoma
- What side effects should I report immediately during Lymphoma treatment
- Hi fellow lymphoma patients. I'm on r-chop with 5 out of 6 infusions. My lungs started hurting a few weeks ago and...
- My husband's lymph nodes on the left side of his neck are enlarged now for 5 month's. Not been sick at all, cbc...
- Starting chemo for 2 weeks before I receive my new cells from Car T Cell therapy the first session is called (RICE )...
- My Lymphoma came back — what are my options now
- How does epigenetic therapy work for Lymphoma
- What is mRNA vaccine therapy for Lymphoma
- Is proton therapy an option for Lymphoma